HEALTH

Subsequent offering period expires for Sun Pharma

BY Allison Cerra

MUMBAI, India Sun Pharmaceutical Industries’ subsequent offering period by one of its subsidiaries for all outstanding ordinary shares for drug maker Taro has expired, Sun Pharma said Wednesday.

Sun subsidiary Alkaloida Chemical Company Exclusive Group was informed that 29,382 ordinary shares of Taro had been tendered as of Tuesday. During the pendency of the subsequent offering period, no additional shares have been tendered. All tendered ordinary shares were accepted for payment.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

KeyVive seeks to improve medication adherence with SMS system

BY Allison Cerra

PARK CITY, Utah A healthcare technology company that uses social media and self-management tools to help people with chronic illnesses is launching a mobile health technology designed to improve adherence.

KeyVive said that its Simplatype mHealth technology, a new SMS system, utilizes proprietary technology with existing cell phone carriers to provide an effective way for practitioners and patients to communicate, store conversations and integrate with electronic records, the company said.

“Our company’s mission is to provide the best healthcare opportunities to professionals in the industry, allowing people to succeed in managing their disease, saving time and money,” said David Greenholtz, president and co-founder of KeyVive. “Pilot groups are currently being implemented, and we are very excited to see how individuals will use their phones to improve their outcomes.”

For more information, visit KeyVive.com.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Kmart Pharmacy supports Breast Cancer Awareness Month with Rx transfer program

BY Allison Cerra

HOFFMAN ESTATES, Ill. — Kmart Pharmacy is introducing an incentive program by which customers will be rewarded for transferring their prescriptions to a Kmart Pharmacy, and the retailer also will support The Breast Cancer Research Foundation.

 

The Transfer for a Cause program, which will run through Oct. 31, encourages customers to consolidate their prescriptions. According to the National Center for Health Statistics, more than 31% of Americans use two or more prescription drugs, which is a 5% increase over the last 10 years. With each qualifying prescription transferred:

  • Kmart Pharmacy customers will receive up to a $20 Kmart gift card. Customers may be eligible to receive up to $100 in Kmart gift cards by transferring their qualifying prescriptions (up to five transferred prescriptions per household) to Kmart Pharmacy; and
  • Kmart will donate $5 to The Breast Cancer Research Foundation — dedicated to preventing breast cancer and finding a cure for the disease — from every eligible prescription transferred to Kmart Pharmacy (up to five transferred prescriptions per household) between now and Oct. 31, with a minimum donation of $10,000.

 

 

"In addition to helping raise funds for The Breast Cancer Research Foundation, consolidating prescriptions is a simple step customers can take that will help give them even more control of their health," said Robb Ayshford, divisional VP pharmacy administration for Kmart. "Recognizing that the number of customers who have multiple prescriptions is increasing, it’s even more important for them to maintain all of them at one pharmacy. At Kmart, our knowledgeable pharmacists will review all prescriptions to help reduce the chance of a drug interaction."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?